REMUUN
Z├╝rich
About REMUUN
REMUUN strives to transform the biotech sector with its revolutionary MEGA therapeutic antibody development platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $169.9K
- Last round: Grant (Mar 2025)
- Website: remuun.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/remuun-223528 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.